Literature DB >> 10395675

Conformational epitope of the type III group B Streptococcus capsular polysaccharide.

W Zou1, R Mackenzie, L Thérien, T Hirama, Q Yang, M A Gidney, H J Jennings.   

Abstract

The protective epitope of the type III group B streptococcal polysaccharide (GBSPIII) is length dependent and conformational. To obtain a more accurate characterization of the conformational epitope, ELISA inhibition and surface plasmon resonance studies were conducted on two GBSPIII-specific mAbs using a large panel of oligosaccharide probes. The results of the studies confirmed that 2 repeating units (RU) is the minimum binding unit and that, while increases in chain length from 2 RU to 7 RU caused further optimization of the epitope, it remained monovalent. A 3-fold increase in affinity was observed between 7 RU and 20 RU, which, by surface plasmon resonance studies on a Fab, was shown to be due to both further optimization of the individual epitope and the occurrence of multivalency of epitope. The data support our hypothesis that the conformational epitope is an extended helical segment of the GBSPIII. GBSPIII exists mainly in the random coil form, which structurally mimics short oligosaccharide self Ags, but it can infrequently and spontaneously form extended helices. Although not prevalent in GBSPIII, the immune system preferentially selects these helical epitopes because they are unique to the polysaccharide. Contrary to a previously proposed model of GBSPIII binding in which the binding of the first Ab propagates a continuum of helical epitopes, our binding kinetics are consistent only with the helical epitope's being discontinuous and infrequent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10395675

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci.

Authors:  E A Albanyan; M S Edwards
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

2.  Structure of the type IX group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII.

Authors:  Francesco Berti; Edmondo Campisi; Chiara Toniolo; Laura Morelli; Stefano Crotti; Roberto Rosini; Maria Rosaria Romano; Vittoria Pinto; Barbara Brogioni; Giulia Torricelli; Robert Janulczyk; Guido Grandi; Immaculada Margarit
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

3.  The immune response to group B streptococcus type III capsular polysaccharide is directed to the -Glc-GlcNAc-Gal- backbone epitope.

Authors:  Dodi Safari; Huberta A T Dekker; Ger T Rijkers; Arie van der Ende; Johannis P Kamerling; Harm Snippe
Journal:  Glycoconj J       Date:  2011-10-08       Impact factor: 2.916

Review 4.  Molecular simulations of carbohydrates and protein-carbohydrate interactions: motivation, issues and prospects.

Authors:  Elisa Fadda; Robert J Woods
Journal:  Drug Discov Today       Date:  2010-06-08       Impact factor: 7.851

5.  Fine specificity and cross-reactions of monoclonal antibodies to group B streptococcal capsular polysaccharide type III.

Authors:  Seth H Pincus; Emily Moran; Grace Maresh; Harold J Jennings; David G Pritchard; Marianne L Egan; Ola Blixt
Journal:  Vaccine       Date:  2012-05-23       Impact factor: 3.641

6.  Understanding the bacterial polysaccharide antigenicity of Streptococcus agalactiae versus Streptococcus pneumoniae.

Authors:  Renuka Kadirvelraj; Jorge Gonzalez-Outeiriño; B Lachele Foley; Meredith L Beckham; Harold J Jennings; Simon Foote; Michael G Ford; Robert J Woods
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-16       Impact factor: 11.205

7.  Structure of a protective epitope of group B Streptococcus type III capsular polysaccharide.

Authors:  Filippo Carboni; Roberto Adamo; Monica Fabbrini; Riccardo De Ricco; Vittorio Cattaneo; Barbara Brogioni; Daniele Veggi; Vittoria Pinto; Irene Passalacqua; Davide Oldrini; Rino Rappuoli; Enrico Malito; Immaculada Y Ros Margarit; Francesco Berti
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

8.  Interplay of Carbohydrate and Carrier in Antibacterial Glycoconjugate Vaccines.

Authors:  Tyler D Moeller; Kevin B Weyant; Matthew P DeLisa
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

9.  Epitope specificities of the group Y and W-135 polysaccharides of Neisseria meningitidis.

Authors:  Samuel L Moore; Catherine Uitz; Chang-Chun Ling; David R Bundle; Peter C Fusco; Francis Michon
Journal:  Clin Vaccine Immunol       Date:  2007-09-05

10.  Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching.

Authors:  Hilde-Kari Guttormsen; Lawrence C Paoletti; Keith G Mansfield; Wojcieck Jachymek; Harold J Jennings; Dennis L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.